Drug information for PRAZEPAM

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CAPSULE; ORAL 5MG Discontinued   PRAZEPAM Prazepam USL PHARMA 70427
CAPSULE; ORAL 10MG Discontinued   PRAZEPAM Prazepam USL PHARMA 70428

Drug Adverse Effects information for PRAZEPAM

Role code Indications Reaction # Reports
SS ANXIETY CONFUSIONAL STATE 1
SS ANXIETY FALL 1
SS ANXIETY GAMMA-GLUTAMYLTRANSFERASE INCREASED 1
SS ANXIETY HEPATOMEGALY 1
SS ANXIETY MULTIPLE DRUG OVERDOSE INTENTIONAL 1
SS ANXIETY SUICIDE ATTEMPT 1
SS ARTHRALGIA CONFUSIONAL STATE 2
SS ARTHRALGIA FALL 2
SS ASPERGILLOSIS DISTURBANCE IN ATTENTION 1
SS ASPERGILLOSIS RENAL FAILURE ACUTE 1
SS BRONCHOPULMONARY ASPERGILLOSIS DISTURBANCE IN ATTENTION 1
SS BRONCHOPULMONARY ASPERGILLOSIS RENAL FAILURE ACUTE 1
SS DEPRESSION BRADYPHRENIA 2
SS DEPRESSION CONFUSIONAL STATE 1
SS DEPRESSION DRUG LEVEL INCREASED 3
SS DEPRESSION FALL 1
SS DEPRESSION FEELING ABNORMAL 2
SS DEPRESSION GAMMA-GLUTAMYLTRANSFERASE INCREASED 1
SS DEPRESSION HEPATOMEGALY 1
SS DEPRESSION INTENTIONAL OVERDOSE 3
SS DEPRESSION MOOD ALTERED 3
SS DEPRESSION SELF-INJURIOUS IDEATION 2
SS DEPRESSION SOCIAL AVOIDANT BEHAVIOUR 1
SS DEPRESSION SOPOR 2
SS FOETAL EXPOSURE DURING PREGNANCY BLOOD PH INCREASED 2
SS FOETAL EXPOSURE DURING PREGNANCY CONGENITAL GENITOURINARY ABNORMALITY 2
SS FOETAL EXPOSURE DURING PREGNANCY CONGENITAL INTESTINAL MALFORMATION 2
SS FOETAL EXPOSURE DURING PREGNANCY GASTROOESOPHAGEAL REFLUX DISEASE 2
SS FOETAL EXPOSURE DURING PREGNANCY MALAISE 2
SS FOETAL EXPOSURE DURING PREGNANCY PYELONEPHRITIS 2
SS FOETAL EXPOSURE DURING PREGNANCY WITHDRAWAL SYNDROME 2
SS HYPERTENSION BRADYPHRENIA 4
SS HYPERTENSION DRUG LEVEL INCREASED 4
SS HYPERTENSION FEELING ABNORMAL 4
SS HYPERTENSION INTENTIONAL OVERDOSE 4
SS HYPERTENSION MOOD ALTERED 4
SS HYPERTENSION SELF-INJURIOUS IDEATION 4
SS HYPERTENSION SOPOR 4
SS INTENTIONAL OVERDOSE BRADYPHRENIA 6
SS INTENTIONAL OVERDOSE DRUG LEVEL INCREASED 6
SS INTENTIONAL OVERDOSE FEELING ABNORMAL 6
SS INTENTIONAL OVERDOSE INTENTIONAL OVERDOSE 6
SS INTENTIONAL OVERDOSE MOOD ALTERED 6
SS INTENTIONAL OVERDOSE SELF-INJURIOUS IDEATION 6
SS INTENTIONAL OVERDOSE SOPOR 6
SS MATERNAL EXPOSURE DURING PREGNANCY ARNOLD-CHIARI MALFORMATION 6
SS MATERNAL EXPOSURE DURING PREGNANCY BLOOD PH INCREASED 2
SS MATERNAL EXPOSURE DURING PREGNANCY GASTROOESOPHAGEAL REFLUX DISEASE 2
SS MATERNAL EXPOSURE DURING PREGNANCY MALAISE 2
SS MATERNAL EXPOSURE DURING PREGNANCY MATERNAL EXPOSURE DURING PREGNANCY 6
SS MATERNAL EXPOSURE DURING PREGNANCY MENINGOCELE 6
SS MATERNAL EXPOSURE DURING PREGNANCY SPINA BIFIDA 6
SS MATERNAL EXPOSURE DURING PREGNANCY WITHDRAWAL SYNDROME 2
SS PRODUCT USED FOR UNKNOWN INDICATION BRADYPNOEA 1
SS PRODUCT USED FOR UNKNOWN INDICATION CONFUSIONAL STATE 2
SS PRODUCT USED FOR UNKNOWN INDICATION CYTOLYTIC HEPATITIS 73
SS PRODUCT USED FOR UNKNOWN INDICATION DEPRESSED LEVEL OF CONSCIOUSNESS 73
SS PRODUCT USED FOR UNKNOWN INDICATION DISORIENTATION 24
SS PRODUCT USED FOR UNKNOWN INDICATION DISTURBANCE IN ATTENTION 16
SS PRODUCT USED FOR UNKNOWN INDICATION DRUG LEVEL INCREASED 3
SS PRODUCT USED FOR UNKNOWN INDICATION FALL 26
SS PRODUCT USED FOR UNKNOWN INDICATION HYPONATRAEMIA 24
SS PRODUCT USED FOR UNKNOWN INDICATION HYPOTHERMIA 73
SS PRODUCT USED FOR UNKNOWN INDICATION INCORRECT DOSE ADMINISTERED 1
SS PRODUCT USED FOR UNKNOWN INDICATION INTENTIONAL DRUG MISUSE 5
SS PRODUCT USED FOR UNKNOWN INDICATION INTENTIONAL OVERDOSE 3
SS PRODUCT USED FOR UNKNOWN INDICATION MOOD ALTERED 3
SS PRODUCT USED FOR UNKNOWN INDICATION MULTIPLE DRUG OVERDOSE INTENTIONAL 83
SS PRODUCT USED FOR UNKNOWN INDICATION RENAL FAILURE ACUTE 16
SS PRODUCT USED FOR UNKNOWN INDICATION RESPIRATORY ACIDOSIS 73
SS PRODUCT USED FOR UNKNOWN INDICATION RESPIRATORY DEPRESSION 72
SS PRODUCT USED FOR UNKNOWN INDICATION SELF INJURIOUS BEHAVIOUR 15
SS PRODUCT USED FOR UNKNOWN INDICATION SLUGGISHNESS 15
SS PRODUCT USED FOR UNKNOWN INDICATION SOCIAL AVOIDANT BEHAVIOUR 3
SS PRODUCT USED FOR UNKNOWN INDICATION SOPOR 5
SS PRODUCT USED FOR UNKNOWN INDICATION SUICIDE ATTEMPT 1
SS PRODUCT USED FOR UNKNOWN INDICATION TOXICITY TO VARIOUS AGENTS 73
SS TOXICITY TO VARIOUS AGENTS BRADYPNOEA 4
SS TOXICITY TO VARIOUS AGENTS CYTOLYTIC HEPATITIS 4
SS TOXICITY TO VARIOUS AGENTS DEPRESSED LEVEL OF CONSCIOUSNESS 4
SS TOXICITY TO VARIOUS AGENTS HYPOTHERMIA 4
SS TOXICITY TO VARIOUS AGENTS INCORRECT DOSE ADMINISTERED 4
SS TOXICITY TO VARIOUS AGENTS RESPIRATORY ACIDOSIS 4
SS TOXICITY TO VARIOUS AGENTS TOXICITY TO VARIOUS AGENTS 4
SS TYPE 2 DIABETES MELLITUS BRADYPHRENIA 2
SS TYPE 2 DIABETES MELLITUS CONFUSIONAL STATE 1
SS TYPE 2 DIABETES MELLITUS DRUG LEVEL INCREASED 2
SS TYPE 2 DIABETES MELLITUS FALL 1
SS TYPE 2 DIABETES MELLITUS FEELING ABNORMAL 2
SS TYPE 2 DIABETES MELLITUS INTENTIONAL OVERDOSE 2
SS TYPE 2 DIABETES MELLITUS MOOD ALTERED 2
SS TYPE 2 DIABETES MELLITUS SELF-INJURIOUS IDEATION 2
SS TYPE 2 DIABETES MELLITUS SOPOR 2
C ABSTAINS FROM ALCOHOL DEATH 4
C ANALGESIC THERAPY ANAPHYLACTIC SHOCK 1
C ANTACID THERAPY DRY SKIN 1
C ANTACID THERAPY PSORIASIS 1
C ANTIVIRAL TREATMENT DRY SKIN 1
C ANTIVIRAL TREATMENT PSORIASIS 1
C ANXIETY AGGRESSION 1
C ANXIETY BIPOLAR I DISORDER 1
C ANXIETY C-REACTIVE PROTEIN INCREASED 2
C ANXIETY DEATH 4
C ANXIETY DEPRESSION 6
C ANXIETY GLOMERULONEPHROPATHY 2
C ANXIETY HAEMATURIA 2
C ANXIETY HYPOALBUMINAEMIA 2
C ANXIETY NEPHROTIC SYNDROME 2
C ANXIETY OBSESSIVE-COMPULSIVE DISORDER 6
C ANXIETY PANCREATITIS ACUTE 2
C ANXIETY PROTEINURIA 2
C ANXIETY PRURITUS GENERALISED 1
C ANXIETY PSYCHOTIC DISORDER 2
C ANXIETY RASH 1
C ANXIETY RENAL FAILURE ACUTE 2
C ANXIETY WHITE BLOOD CELL COUNT INCREASED 2
C ANXIOLYTIC THERAPY DRY SKIN 1
C ANXIOLYTIC THERAPY PSORIASIS 1
C CHRONIC OBSTRUCTIVE PULMONARY DISEASE BRONCHOSPASM 1
C CHRONIC OBSTRUCTIVE PULMONARY DISEASE PULMONARY CONGESTION 1
C COLITIS C-REACTIVE PROTEIN INCREASED 2
C COLITIS GLOMERULONEPHROPATHY 2
C COLITIS HAEMATURIA 2
C COLITIS HYPOALBUMINAEMIA 2
C COLITIS NEPHROTIC SYNDROME 2
C COLITIS PANCREATITIS ACUTE 2
C COLITIS PROTEINURIA 2
C COLITIS RENAL FAILURE ACUTE 2
C COLITIS WHITE BLOOD CELL COUNT INCREASED 2
C DEPRESSED MOOD AGITATION 1
C DEPRESSED MOOD ANXIETY 1
C DEPRESSED MOOD COAGULOPATHY 1
C DEPRESSED MOOD DEPRESSED MOOD 1
C DEPRESSED MOOD INTENTIONAL DRUG MISUSE 1
C DEPRESSED MOOD PULMONARY EMBOLISM 2
C DEPRESSED MOOD WRONG TECHNIQUE IN DRUG USAGE PROCESS 1
C DEPRESSION DEPRESSION 6
C DEPRESSION OBSESSIVE-COMPULSIVE DISORDER 6
C DYSLIPIDAEMIA ALANINE AMINOTRANSFERASE INCREASED 1
C DYSLIPIDAEMIA ASPARTATE AMINOTRANSFERASE INCREASED 1
C DYSLIPIDAEMIA GAMMA-GLUTAMYLTRANSFERASE INCREASED 1
C DYSLIPIDAEMIA LIPASE INCREASED 1
C DYSLIPIDAEMIA PYREXIA 1
C EPILEPSY C-REACTIVE PROTEIN INCREASED 2
C EPILEPSY GLOMERULONEPHROPATHY 2
C EPILEPSY HAEMATURIA 2
C EPILEPSY HYPOALBUMINAEMIA 2
C EPILEPSY NEPHROTIC SYNDROME 2
C EPILEPSY PANCREATITIS ACUTE 2
C EPILEPSY PROTEINURIA 2
C EPILEPSY RENAL FAILURE ACUTE 2
C EPILEPSY WHITE BLOOD CELL COUNT INCREASED 2
C HEART TRANSPLANT CYTOMEGALOVIRUS INFECTION 3
C HEART TRANSPLANT LUNG DISORDER 3
C HEART TRANSPLANT LYMPHOEDEMA 3
C HEART TRANSPLANT OEDEMA PERIPHERAL 3
C HEART TRANSPLANT WEIGHT INCREASED 3
C HEPATITIS C AGGRESSION 3
C HEPATITIS C CHEST PAIN 9
C HEPATITIS C EPISTAXIS 9
C HEPATITIS C HEADACHE 9
C HEPATITIS C MUSCULAR WEAKNESS 9
C HEPATITIS C RASH 3
C HEPATITIS C VISION BLURRED 3
C HIV INFECTION DEATH 4
C HYPERCHOLESTEROLAEMIA AGITATION 1
C HYPERCHOLESTEROLAEMIA ANXIETY 1
C HYPERCHOLESTEROLAEMIA COAGULOPATHY 1
C HYPERCHOLESTEROLAEMIA DEPRESSED MOOD 1
C HYPERCHOLESTEROLAEMIA PULMONARY EMBOLISM 1
C HYPERCHOLESTEROLAEMIA WRONG TECHNIQUE IN DRUG USAGE PROCESS 1
C HYPERTENSION ALANINE AMINOTRANSFERASE INCREASED 1
C HYPERTENSION ASPARTATE AMINOTRANSFERASE INCREASED 1
C HYPERTENSION DECREASED APPETITE 1
C HYPERTENSION DRY SKIN 1
C HYPERTENSION FALL 1
C HYPERTENSION GAMMA-GLUTAMYLTRANSFERASE INCREASED 1
C HYPERTENSION GENERAL PHYSICAL HEALTH DETERIORATION 1
C HYPERTENSION HAEMODIALYSIS 1
C HYPERTENSION HYPERKALAEMIA 1
C HYPERTENSION KIDNEY SMALL 1
C HYPERTENSION LIPASE INCREASED 1
C HYPERTENSION METABOLIC ACIDOSIS 1
C HYPERTENSION PSORIASIS 1
C HYPERTENSION PYREXIA 1
C HYPERTENSION RENAL DISORDER 1
C HYPERTENSION RENAL FAILURE ACUTE 1
C IMPULSE-CONTROL DISORDER ABNORMAL BEHAVIOUR 1
C IMPULSE-CONTROL DISORDER ANXIETY 1
C IMPULSE-CONTROL DISORDER AUTONOMIC NERVOUS SYSTEM IMBALANCE 1
C IMPULSE-CONTROL DISORDER DEPRESSION 1
C IMPULSE-CONTROL DISORDER DRUG INEFFECTIVE 1
C IMPULSE-CONTROL DISORDER FATIGUE 1
C IMPULSE-CONTROL DISORDER LETHARGY 1
C IMPULSE-CONTROL DISORDER SOMNOLENCE 1
C IMPULSE-CONTROL DISORDER WEIGHT INCREASED 1
C IMPULSE-CONTROL DISORDER WHITE BLOOD CELL COUNT DECREASED 1
C INFLUENZA LIKE ILLNESS CHEST PAIN 3
C INFLUENZA LIKE ILLNESS EPISTAXIS 3
C INFLUENZA LIKE ILLNESS HEADACHE 3
C INFLUENZA LIKE ILLNESS MUSCULAR WEAKNESS 3
C INFLUENZA LIKE ILLNESS VISION BLURRED 1
C INSOMNIA CHEST PAIN 3
C INSOMNIA EPISTAXIS 3
C INSOMNIA HEADACHE 3
C INSOMNIA MUSCULAR WEAKNESS 3
C INSOMNIA VISION BLURRED 1
C LUNG ADENOCARCINOMA APHASIA 1
C LUNG ADENOCARCINOMA MEMORY IMPAIRMENT 1
C LUNG ADENOCARCINOMA REVERSIBLE ISCHAEMIC NEUROLOGICAL DEFICIT 1
C LUNG ADENOCARCINOMA VISUAL FIELD DEFECT 1
C LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0 APHASIA 1
C LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0 MEMORY IMPAIRMENT 1
C LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0 REVERSIBLE ISCHAEMIC NEUROLOGICAL DEFICIT 1
C LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE 0 VISUAL FIELD DEFECT 1
C LUNG NEOPLASM MALIGNANT C-REACTIVE PROTEIN INCREASED 2
C LUNG NEOPLASM MALIGNANT GLOMERULONEPHROPATHY 2
C LUNG NEOPLASM MALIGNANT HAEMATURIA 2
C LUNG NEOPLASM MALIGNANT HYPOALBUMINAEMIA 2
C LUNG NEOPLASM MALIGNANT NEPHROTIC SYNDROME 2
C LUNG NEOPLASM MALIGNANT PANCREATITIS ACUTE 2
C LUNG NEOPLASM MALIGNANT PROTEINURIA 2
C LUNG NEOPLASM MALIGNANT RENAL FAILURE ACUTE 2
C LUNG NEOPLASM MALIGNANT REVERSIBLE ISCHAEMIC NEUROLOGICAL DEFICIT 1
C LUNG NEOPLASM MALIGNANT WHITE BLOOD CELL COUNT INCREASED 2
C LYMPHOCYTIC LYMPHOMA BLOOD DISORDER 1
C LYMPHOCYTIC LYMPHOMA DEAFNESS 1
C LYMPHOCYTIC LYMPHOMA PYREXIA 1
C LYMPHOCYTIC LYMPHOMA TINNITUS 1
C LYMPHOCYTIC LYMPHOMA TOXIC SKIN ERUPTION 1
C MAJOR DEPRESSION MYOCARDIAL INFARCTION 3
C MULTIPLE SCLEROSIS DEPRESSION 2
C MULTIPLE SCLEROSIS OBSESSIVE-COMPULSIVE DISORDER 2
C NERVOUSNESS CHEST PAIN 6
C NERVOUSNESS EPISTAXIS 6
C NERVOUSNESS HEADACHE 6
C NERVOUSNESS MUSCULAR WEAKNESS 6
C NERVOUSNESS VISION BLURRED 2
C NON-SMALL CELL LUNG CANCER REVERSIBLE ISCHAEMIC NEUROLOGICAL DEFICIT 1
C OSTEOARTHRITIS DECREASED APPETITE 1
C OSTEOARTHRITIS FALL 1
C OSTEOARTHRITIS GENERAL PHYSICAL HEALTH DETERIORATION 1
C OSTEOARTHRITIS HAEMODIALYSIS 1
C OSTEOARTHRITIS HYPERKALAEMIA 1
C OSTEOARTHRITIS KIDNEY SMALL 1
C OSTEOARTHRITIS METABOLIC ACIDOSIS 1
C OSTEOARTHRITIS RENAL DISORDER 1
C OSTEOARTHRITIS RENAL FAILURE ACUTE 1
C PARKINSON'S DISEASE ABNORMAL BEHAVIOUR 9
C PARKINSON'S DISEASE AGITATION 9
C PARKINSON'S DISEASE AKINESIA 9
C PARKINSON'S DISEASE AMIMIA 9
C PARKINSON'S DISEASE BACK PAIN 9
C PARKINSON'S DISEASE BALANCE DISORDER 9
C PARKINSON'S DISEASE C-REACTIVE PROTEIN INCREASED 9
C PARKINSON'S DISEASE CHROMATURIA 9
C PARKINSON'S DISEASE COMPULSIVE SHOPPING 9
C PARKINSON'S DISEASE CORNEAL REFLEX DECREASED 9
C PARKINSON'S DISEASE DEPRESSED MOOD 9
C PARKINSON'S DISEASE DEPRESSION 9
C PARKINSON'S DISEASE DYSPNOEA 9
C PARKINSON'S DISEASE DYSTHYMIC DISORDER 9
C PARKINSON'S DISEASE FALL 9
C PARKINSON'S DISEASE HYPOMANIA 9
C PARKINSON'S DISEASE IRRITABILITY 9
C PARKINSON'S DISEASE MUSCLE RIGIDITY 9
C PARKINSON'S DISEASE MUSCLE SPASMS 9
C PARKINSON'S DISEASE MUSCULOSKELETAL PAIN 9
C PARKINSON'S DISEASE NECK PAIN 9
C PARKINSON'S DISEASE NEUROSIS 9
C PARKINSON'S DISEASE PSYCHOMOTOR HYPERACTIVITY 9
C PARKINSON'S DISEASE PSYCHOTIC BEHAVIOUR 9
C PARKINSON'S DISEASE RED BLOOD CELL SEDIMENTATION RATE INCREASED 9
C PARKINSON'S DISEASE SUICIDAL IDEATION 9
C PARKINSON'S DISEASE SUICIDE ATTEMPT 9
C PARKINSON'S DISEASE THYMUS DISORDER 9
C PARKINSON'S DISEASE TREMOR 9
C PARKINSON'S DISEASE WEIGHT INCREASED 9
C PLATELET AGGREGATION INHIBITION DRY SKIN 1
C PLATELET AGGREGATION INHIBITION PSORIASIS 1
C PLEURAL MESOTHELIOMA BLOOD DISORDER 3
C PLEURAL MESOTHELIOMA DEAFNESS 3
C PLEURAL MESOTHELIOMA PYREXIA 3
C PLEURAL MESOTHELIOMA TINNITUS 3
C PLEURAL MESOTHELIOMA TOXIC SKIN ERUPTION 3
C PREMEDICATION BLOOD DISORDER 5
C PREMEDICATION DEAFNESS 5
C PREMEDICATION PYREXIA 5
C PREMEDICATION TINNITUS 5
C PREMEDICATION TOXIC SKIN ERUPTION 5
C PRODUCT USED FOR UNKNOWN INDICATION APHASIA 5
C PRODUCT USED FOR UNKNOWN INDICATION DECREASED APPETITE 5
C PRODUCT USED FOR UNKNOWN INDICATION DEMENTIA 5
C PRODUCT USED FOR UNKNOWN INDICATION DIET REFUSAL 5
C PRODUCT USED FOR UNKNOWN INDICATION DISTURBANCE IN ATTENTION 5
C PRODUCT USED FOR UNKNOWN INDICATION DRUG LEVEL INCREASED 5
C PRODUCT USED FOR UNKNOWN INDICATION FAILURE TO THRIVE 5
C PRODUCT USED FOR UNKNOWN INDICATION MYOCLONUS 4
C PRODUCT USED FOR UNKNOWN INDICATION RENAL FAILURE ACUTE 5
C PRODUCT USED FOR UNKNOWN INDICATION SOMNOLENCE 5
C PROPHYLAXIS ANAPHYLACTIC SHOCK 1
C PROPHYLAXIS AGAINST HIV INFECTION CARPAL TUNNEL SYNDROME 2
C PROPHYLAXIS AGAINST HIV INFECTION DIARRHOEA 1
C PROPHYLAXIS AGAINST TRANSPLANT REJECTION DRY SKIN 3
C PROPHYLAXIS AGAINST TRANSPLANT REJECTION PSORIASIS 3
C PSORIASIS BIPOLAR I DISORDER 1
C PSORIASIS PRURITUS GENERALISED 1
C PSORIASIS PSYCHOTIC DISORDER 2
C SCHIZOPHRENIA DELUSION OF REFERENCE 1
C SCHIZOPHRENIA SUICIDAL IDEATION 1
C SCHIZOPHRENIA TRISMUS 1
C SLEEP DISORDER AGITATION 1
C SLEEP DISORDER ANXIETY 1
C SLEEP DISORDER COAGULOPATHY 1
C SLEEP DISORDER DEPRESSED MOOD 1
C SLEEP DISORDER INTENTIONAL DRUG MISUSE 1
C SLEEP DISORDER PULMONARY EMBOLISM 2
C SLEEP DISORDER WRONG TECHNIQUE IN DRUG USAGE PROCESS 1
C SMOKING CESSATION THERAPY DEATH 16
C TONSILLITIS MYOCLONUS 2
C TUBERCULOSIS BIPOLAR I DISORDER 1
C TUBERCULOSIS PRURITUS GENERALISED 1
C TUBERCULOSIS PSYCHOTIC DISORDER 2
C TYPE 2 DIABETES MELLITUS ALANINE AMINOTRANSFERASE INCREASED 4
C TYPE 2 DIABETES MELLITUS ASPARTATE AMINOTRANSFERASE INCREASED 4
C TYPE 2 DIABETES MELLITUS GAMMA-GLUTAMYLTRANSFERASE INCREASED 4
C TYPE 2 DIABETES MELLITUS LIPASE INCREASED 4
C TYPE 2 DIABETES MELLITUS PYREXIA 4
Ads by Google